Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of the Use of Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting in Austria, Germany and Switzerland

NCT03342144 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT03342144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03342144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of the Use of Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting in Austria, Germany and Switzerland
Lead sponsor
AbbVie
Phase
Observational
Overall status
Recruiting
Start date
December 4, 2017
Completion date
December 31, 2030
Enrollment
500 (estimated)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia (cll)